Idiopathic anterior uveitis accounts for a significant portion of uveitis and is responsible for localized intraocular inflammation. The case presents a long-term follow-up of a 38-year-old patient with a unilateral, recurrent and childhood-onset IAU. The patient encounters flare-ups approximately every six months, which are treated with topical corticosteroids and mydriatics, leading to quick resolution without lasting complications or visual acuity decline. Comprehensive diagnostic work-up ruled out infectious and autoimmune causes, highlighting the disease's purely ocular involvement. Examination of local immune reactions in the anterior chamber of eyes affected by IAU is crucial, as together with immune memory may persist even after clinical recovery. These mechanisms account for the persistent nature of inflammation and the drawbacks of existing topical treatments, which manage acute flare-ups but fail to address the fundamental immune dysregulation. New targeted strategies, such as locally delivered biologics or cytokine-modulating agents, could reduce recurrence while limiting systemic exposure. This case highlights the significance of localized ocular immune activation and underscores the necessity for treatments aimed at the root immunopathogenesis of IAU.
Kolti et al. (Fri,) studied this question.